Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Park Ha Biological Technology ( (BYAH) ).
On March 6, 2026, Park Ha Biological Technology disclosed that it had received confirmation from Nasdaq that its Class A ordinary shares regained compliance with the exchange’s minimum bid price requirement. The company’s stock closed at or above $1.00 per share for ten consecutive trading days from February 20 through March 5, 2026, resolving the prior deficiency and removing an immediate risk to its continued listing on the Nasdaq Capital Market.
The restored compliance stabilizes Park Ha Biological Technology’s U.S. listing status and may help support investor confidence and liquidity in its shares. By closing this matter with Nasdaq, the company avoids potential delisting actions, preserving access to a key equity financing platform that can be important for growth-focused life sciences issuers.
More about Park Ha Biological Technology
Park Ha Biological Technology Co., Ltd. is a China-based life sciences company headquartered in Wuxi, Jiangsu Province, operating from the Wuxi International Life Science Innovation Campus. The company’s Class A ordinary shares are listed on the Nasdaq Capital Market, giving it access to U.S. capital markets and global investors.
Average Trading Volume: 270,025
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.49M
For detailed information about BYAH stock, go to TipRanks’ Stock Analysis page.